Reported Consolidated quarterly numbers for Transgene Biotek are:Net Sales at Rs 0.08 crore in March 2025 up 70% from Rs. 0.05 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.71 crore in March 2025 down 161.88% from Rs. 0.27 crore in March 2024.
EBITDA stands negative at Rs. 0.50 crore in March 2025 down 127.27% from Rs. 0.22 crore in March 2024.
Transgene Biote shares closed at 3.50 on May 06, 2025 (BSE) and has given -46.24% returns over the last 6 months and -50.00% over the last 12 months.
| Transgene Biotek | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 0.08 | 0.08 | 0.05 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 0.08 | 0.08 | 0.05 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | 0.00 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.06 | 0.08 | 0.08 | | Depreciation | 0.02 | 0.02 | 0.02 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.56 | 0.09 | 0.24 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -0.57 | -0.12 | -0.29 | | Other Income | 0.04 | 0.04 | 0.05 | | P/L Before Int., Excpt. Items & Tax | -0.52 | -0.07 | -0.24 | | Interest | 0.19 | 0.02 | 0.03 | | P/L Before Exceptional Items & Tax | -0.71 | -0.09 | -0.27 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.71 | -0.09 | -0.27 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -0.71 | -0.09 | -0.27 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.71 | -0.09 | -0.27 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -0.71 | -0.09 | -0.27 | | Equity Share Capital | 75.77 | 75.77 | 75.77 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.09 | -0.01 | -0.04 | | Diluted EPS | -0.09 | -0.01 | -0.04 | | EPS After Extra Ordinary | | Basic EPS | -0.09 | -0.01 | -0.04 | | Diluted EPS | -0.09 | -0.01 | -0.04 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
